Dendritic cell CD83: a therapeutic target or innocent bystander? - Wikidata - wikimedia - TriplyDB

Dendritic cell CD83: a therapeutic target or innocent bystander?

Dendritic cell CD83: a therapeutic target or innocent bystander?

http://www.wikidata.org/entity/Q37000947

about

Functional characterization of the HuR:CD83 mRNA interaction.CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.Targeting membrane proteins for antibody discovery using phage display.Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison.Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.Dendritic cells and their role in tumor immunosurveillance.Cellular and molecular mechanisms in graft-versus-host disease.The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus.Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.Malaria-derived hemozoin exerts early modulatory effects on the phenotype and maturation of human dendritic cells.Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus.Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system.Targeting CD83 for the treatment of graft-versus-host disease.In vitro comparison of commensal, probiotic and pathogenic strains of Enterococcus faecalis.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.

P2860

Q33988827-E84958DB-387A-4C3C-A09B-A4E7A3A2A009 Q34501441-9060E3E4-7A8E-431C-B601-E0D2C5FD76E2 Q35106954-D79D4242-5B90-4692-9573-4F9AC8E6DD44 Q36020577-2E91E727-950C-4BED-B104-DB9153B1B154 Q36124064-EECB0F89-DC80-4936-AD69-6D809FFCD679 Q37197974-9E22F390-C9CB-43B6-81C4-3369F81FBF0C Q37206697-2017EB27-5707-4164-91B5-BC35FEF7A80C Q37681536-1CDD61B8-1025-41F6-986D-808C9AF6AAFA Q38021625-C05EAB58-B9E0-4487-9B62-6D4565CC62D7 Q38661579-610EC910-96E2-4DC0-AC15-D9E754BFA93B Q39233053-7C8E373D-F9D2-4819-80BA-D4A77B0005C4 Q39733403-C1753204-27DD-4B5B-B998-9FEAEB042DF5 Q40563795-C8A95160-D0E0-40AC-9E2E-993111919A24 Q40703127-265A115A-D1E7-4A7A-91C5-ED50A0730684 Q40933810-A9466B42-CBDF-4823-98E7-8F5163EA9E81 Q43104684-AD4EAC77-E55A-4947-A40F-FF769403B8E9 Q43725901-20EEE690-5D81-45FD-91D0-B40B0AF3B15F Q54937398-789A8F65-9576-4751-A6ED-F01DC803C4DB Q55342016-F99D7BFE-A255-4D67-AE50-6AEBCC90DFF1

P2860

Dendritic cell CD83: a therapeutic target or innocent bystander?

http://www.wikidata.org/entity/Q37000947

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 October 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dendritic cell CD83: a therapeutic target or innocent bystander?

@en

Dendritic cell CD83: a therapeutic target or innocent bystander?

@nl

type

label

Dendritic cell CD83: a therapeutic target or innocent bystander?

@en

Dendritic cell CD83: a therapeutic target or innocent bystander?

@nl

prefLabel

Dendritic cell CD83: a therapeutic target or innocent bystander?

@en

Dendritic cell CD83: a therapeutic target or innocent bystander?

@nl

P1433

Q37000947-BA8390D0-B6A8-43D5-BBC8-B252244AD84A

P1476

Q37000947-4AB4A368-BEA4-4C53-8D30-A23B55CA37E4

P2093

Q37000947-7A8BC9EE-3104-41A4-829D-C3E20E96D074

Q37000947-9B184F0E-3411-48A1-AE0D-2C527CF56133

P2860

Q37000947-152D41BC-0CDF-4E59-B513-963DB453248F

Q37000947-1747010B-40FC-4CB7-A990-5217C58A3BDB

Q37000947-250BC9E6-4E37-4C6F-A514-E3ACE9B0E126

Q37000947-2725EC67-BF58-4071-87A7-60C9D2259AEE

Q37000947-2E3A0044-9887-4FD0-AA7F-33E4303B32CC

Q37000947-397DC8EB-FEDB-4005-8FED-A610A43257B3

Q37000947-3B257F66-0C67-4249-AC29-D62126245443

Q37000947-3C729DBB-5DC3-442F-ACF0-A2251F771E0C

Q37000947-447D0B4E-3079-4022-A275-01236D84F535

Q37000947-489232E8-ACAC-41C5-9365-F4E457FAE0F6

P304

Q37000947-5CA93B7C-45CB-477A-A431-8BFA852B80E7

P31

Q37000947-88001858-1FFE-4FE1-9D24-8D25A1335F70

P356

Q37000947-4EE32C0A-B839-49BC-A071-446B5193B769

P433

Q37000947-8F1CB656-154D-43E7-B931-F9C2F94EB22A

P478

Q37000947-6D9CAB9C-C246-4669-86F5-2B3AD67A41DE

P577

Q37000947-D8B4BFFE-D233-4E06-84D3-564BFDA4B734

P5875

Q37000947-AC6E9101-C900-4E85-A10C-C664D437585F

P698

Q37000947-A3FDACAC-E736-40F4-86AA-C6F44C950ED2

P932

Q37000947-A21B99AC-A888-4C47-B775-36753A527417

P356

J.IMLET.2007.10.001

P1433

Immunology Letters

P1476

Dendritic cell CD83: a therapeutic target or innocent bystander?

@en

P2093

Charlene M Prazma

http://www.w3.org/2001/XMLSchema#string

Thomas F Tedder

http://www.w3.org/2001/XMLSchema#string

P2860

A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily

Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes

CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells

Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells

Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation.

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMLET.2007.10.001

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5844830

http://www.w3.org/2001/XMLSchema#string

P698

18001846

http://www.w3.org/2001/XMLSchema#string

P932

2699889

http://www.w3.org/2001/XMLSchema#string